Join GitHub today
GitHub is home to over 40 million developers working together to host and review code, manage projects, and build software together.
Sign upSynthesis of 4-(5-(2-methoxy-2-methylpropoxy)-[1,2,4]triazolo[4,3-a]pyrazin-3-yl)benzonitrile #238
Milestone
Comments
This comment has been minimized.
This comment has been minimized.
Currently closing para nitrile compounds as para-difluoromethoxy compounds were preferentially targeted (http://malaria.ourexperiment.org/biological_data/11080/Results_for_samples_sent_for_in_vitro_efficacy_evaluation_against_Plasmodium_falciparum_asexual_blood_stage.html) We may revisit these compounds in relation to #304 but currently prioritising compounds here #358. |
Sign up for free
to join this conversation on GitHub.
Already have an account?
Sign in to comment
Following discussion (Issue #232) a selection of target compounds for the second round of biological evaluation for the triazolopyrazines.
This compound is a representative example from the chiral ethers that could be resolved by preparative HPLC at a later stage in the project. It also meets 3 of the 4 ESAC criteria:
Aim for log P between 1.5 and 3.5 (well CLogP...need to clarify)

Revisit other cores with good metabolic profiles, e.g. MMV669846
Use more sp3 carbons, and de-planarize through chirality at C-5 or in substitutions at C-2 or C-5